Ponesimod, Up for Approval, Shows ‘Clear Superiority’ Over Aubagio, Janssen Exec Says
Ponesimod may soon be a new oral therapy for people with relapsing multiple sclerosis (MS) in Europe, and a…
Articles by Marisa Wexler, MS
Janssen Asks EMA to Approve Oral Ponesimod to Treat Relapsing MS
Janssen has submitted an application to the European Medicines Agency (EMA) asking that ponesimod be approved as…
Masitinib Slows Disability Progression in PPMS and Non-active SPMS, Phase 2/3 Trial Reports
AB Science‘s masitinib significantly slowed disability progression in people with primary progressive multiple sclerosis (PPMS) and non-active…
Number of People with MS in UK More Than Previously Estimated
New data from Public Health England (PHE) and the U.K. MS Society show that the number of people…
Cognitive Decline in MS May Not Be Inevitable or Progressive, 10-year Study Suggests
Progressive cognitive decline in patients with multiple sclerosis (MS) may not be as inevitable as previously thought, a study…
Mavenclad May Be Added to RRMS Treatments on Quebec’s Public Health Plan
The agency in charge of health and social services for Quebec, known as the Institut national d’excellence en santé et…
Mayzent Approved in Europe as First Oral Treatment for Active Secondary Progressive MS
The experimental BTK inhibitor SAR442168 showed an acceptable safety profile and met its primary endpoint — a significant…
MSAA Marks 50th Anniversary with Benefit Evening, New Logo and More
The Multiple Sclerosis Association of America (MSAA) is celebrating 50 years of work and dedication to improving the lives…
Mental Health of Women Affected by Caring for Children with MS, Study Suggests
Caring for children with multiple sclerosis (MS) can affect the mental health of their mothers over the long term,…
NICE Approves Plegridy as RRMS Treatment Offered by NHS England
The National Institute for Health Care and Excellence (NICE) in the U.K. issued its final decision, approving the inclusion…
Gene Variants Linked to High Childhood BMI Point to Higher MS Risk, Study Finds
Genetic variations that increase body mass index (BMI) in childhood are associated with a higher risk of multiple sclerosis (MS)…
Memory Training Could Make Brains of MS Patients More Efficient, Study Suggests
People with multiple sclerosis (MS) who complete training through a method called the modified Story Memory Technique (mSMT)…
Scottish Medicines Consortium Approves Ocrevus for Treating PPMS
Ocrevus (ocrelizumab) has been approved in Scotland as a treatment for early, inflammatory primary progressive multiple sclerosis (PPMS).
First MS Patient Dosed in Phase 2 Trial of Potential Remyelinating Therapy CNM-Au8, Clene Announces
The first participant has been dosed in the Phase 2 REPAIR-MS clinical trial examining the effects of CNM-Au8, Clene…
US Patent Issued for Anavex 2-73 for Treatment of Neurodevelopmental Disorders, Including MS
Anavex Life Sciences has received a U.S. patent covering the use of Anavex 2-73 (blarcamesine) for the treatment of…
Gabapentinoid Use to Control MS Pain Can Lead to Respiratory Problems, FDA Warns
Gabapentinoids — a class of therapies sometimes used off-label to help control pain in people with multiple sclerosis (MS)…
Timing Speed of Eye-to-Brain Signals May Be Way of Measuring Myelin Changes, Study Says
Measuring the speed of signals sent to the brain by nerves in the eye could help assess if remyelination is…
Einstein Researchers Receive Grant to Study Brain Activity Related to Fall Risk in MS Patients
A grant awarded recently by the National Institutes of Health (NIH) will fund research to explore how brain changes…
Sitting Less, Walking More May Be Feasible Way to Healthier Life with MS, Study Suggests
Small changes in daily activities, like sitting less and walking more, may be healthful for people with multiple sclerosis…
MetP Pharma Awarded US Patent for Potential Remyelination Therapy
MetP Pharma‘s patent application for a new method to treat demyelinating and neuroinflammatory diseases, including multiple sclerosis (MS),…
Atlas Biotechnologies to Fund Research into Cannabis Treatment for MS, Similar Diseases
Atlas Biotechnologies will fund and provide support to three research projects at the University of Alberta to possibly identify cannabis…
Profit and Competitors’ Prices Major Drivers of MS Therapy Costs in US, Pharma Execs Say
Prices for new multiple sclerosis (MS) therapies in the United States are decided most by competitors’ prices, and continual increases in…
WCN 2019 Discussions Point to Failures of Regulators to Make MS Therapies Available
There is a sizable gap between advancements in treatment for multiple sclerosis (MS)Â and their regulatory approval, which is a…
Levels of Infection-fighting Antibodies Low in Blood of People with MS, Study Finds
People with multiple sclerosis (MS) tend to have low levels in their blood serum of certain antibodies that can…
AP-1 Transcription Factor Family is Critical for Healthy T-cell Development, Study Says
The transcription factor family AP-1 is crucial for the proper activation of immune T-cells, a new study shows, and this…
Metformin Works to Promote Remyelination in Ways Similar to Fasting, Study Says
Metformin, a common diabetes treatment that works to mimic dietary fasting, was seen to promote remyelination in the stem…
RRMS Patients Not Using DMTs More Likely to Have Been Misdiagnosed, Cite Poorer Relationships with Doctors, Survey Says
People with relapsing-remitting multiple sclerosis (RRMS) who don’t use disease-modifying therapies (DMTs) are more likely to have been misdiagnosed…
ExeGi Pharma’s Probiotic Visbiome Will Be Tested in MS Clinical Trial
ExeGi Pharma announced a new clinical trial testing its probiotic Visbiome in people with multiple sclerosis (MS). The…
New App May Help Measure Cognitive Function in MS Patients, Study Reports
A new app might make it easier for healthcare providers to assess cognitive function in people with multiple sclerosis…
MRI Marker May Be Better at Predicting MS Disease Progression, Study Finds
The volume of atrophied (shrunken) regions in the brain, as visible through magnetic resonance imaging (MRI) scans, can predict disease…